BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 22394384)

  • 1. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system.
    Echeverry R; Wu F; Haile WB; Wu J; Yepes M
    J Neuroinflammation; 2012 Mar; 9():45. PubMed ID: 22394384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death.
    Haile WB; Echeverry R; Wu F; Guzman J; An J; Wu J; Yepes M
    Neuroscience; 2010 Dec; 171(4):1256-64. PubMed ID: 20955770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.
    Haile WB; Echeverry R; Wu J; Yepes M
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1147-56. PubMed ID: 20068578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.
    Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation.
    Wilhelm A; Shepherd EL; Amatucci A; Munir M; Reynolds G; Humphreys E; Resheq Y; Adams DH; Hübscher S; Burkly LC; Weston CJ; Afford SC
    J Pathol; 2016 May; 239(1):109-21. PubMed ID: 26924336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD.
    Chopra M; Brandl A; Siegmund D; Mottok A; Schäfer V; Biehl M; Kraus S; Bäuerlein CA; Ritz M; Mattenheimer K; Schwinn S; Seher A; Grabinger T; Einsele H; Rosenwald A; Brunner T; Beilhack A; Wajant H
    Blood; 2015 Jul; 126(4):437-44. PubMed ID: 26012567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
    Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
    J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia.
    Yepes M; Brown SA; Moore EG; Smith EP; Lawrence DA; Winkles JA
    Am J Pathol; 2005 Feb; 166(2):511-20. PubMed ID: 15681834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
    Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
    Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson's disease.
    Mustafa S; Martin HL; Burkly L; Costa A; Martins ML; Schwaninger M; Teismann P
    Neuroscience; 2016 Apr; 319():116-22. PubMed ID: 26808775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.
    Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W
    PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
    Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
    Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
    Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
    J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus.
    Zhao Z; Burkly LC; Campbell S; Schwartz N; Molano A; Choudhury A; Eisenberg RA; Michaelson JS; Putterman C
    J Immunol; 2007 Dec; 179(11):7949-58. PubMed ID: 18025243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration.
    Potrovita I; Zhang W; Burkly L; Hahm K; Lincecum J; Wang MZ; Maurer MH; Rossner M; Schneider A; Schwaninger M
    J Neurosci; 2004 Sep; 24(38):8237-44. PubMed ID: 15385607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Src homology 3 domain-containing guanine nucleotide exchange factor is overexpressed in high-grade gliomas and promotes tumor necrosis factor-like weak inducer of apoptosis-fibroblast growth factor-inducible 14-induced cell migration and invasion via tumor necrosis factor receptor-associated factor 2.
    Fortin Ensign SP; Mathews IT; Eschbacher JM; Loftus JC; Symons MH; Tran NL
    J Biol Chem; 2013 Jul; 288(30):21887-97. PubMed ID: 23775076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function.
    Fortin SP; Ennis MJ; Savitch BA; Carpentieri D; McDonough WS; Winkles JA; Loftus JC; Kingsley C; Hostetter G; Tran NL
    Mol Cancer Res; 2009 Nov; 7(11):1871-81. PubMed ID: 19861406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.
    Campbell S; Burkly LC; Gao HX; Berman JW; Su L; Browning B; Zheng T; Schiffer L; Michaelson JS; Putterman C
    J Immunol; 2006 Feb; 176(3):1889-98. PubMed ID: 16424220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14).
    Fick A; Lang I; Schäfer V; Seher A; Trebing J; Weisenberger D; Wajant H
    J Biol Chem; 2012 Jan; 287(1):484-495. PubMed ID: 22081603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TWEAK-Fn14 system as a potential drug target.
    Wajant H
    Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.